Sign up to save your podcasts
Or
Share Parkinson’s and suicide risk; biomarkers and underrepresentation in Alzheimer’s trials, immune system changes in ALS and Parkinson’s.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Parkinson’s and suicide risk; biomarkers and underrepresentation in Alzheimer’s trials, immune system changes in ALS and Parkinson’s.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson’s patients; underrepresentation of non-White people in Alzheimer’s trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson’s patients; underrepresentation of non-White people in Alzheimer’s trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
132 Listeners
Global News Podcast
7,683 Listeners
Neurology® Podcast
285 Listeners
NEJM This Week
322 Listeners
Practical Neurology Podcast
45 Listeners
JAMA Clinical Reviews
496 Listeners
JAMA Neurology Author Interviews
14 Listeners
Annals On Call Podcast
186 Listeners
The Clinical Problem Solvers
514 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
363 Listeners
The Lancet Neurology in conversation with
2 Listeners
Continuum Audio
77 Listeners